480 related articles for article (PubMed ID: 12382158)
21. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
Hauer KE
West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
[TBL] [Abstract][Full Text] [Related]
22. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis.
Singh K; Yakoub D; Giangola P; DeCicca M; Patel CA; Marzouk F; Giangola G
J Vasc Surg; 2012 Jan; 55(1):136-40. PubMed ID: 21982332
[TBL] [Abstract][Full Text] [Related]
23. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
Heidenreich C; Hohmann V; Bramlage P
Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
[TBL] [Abstract][Full Text] [Related]
24. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage.
Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H
Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH).
Holzheimer RG
Eur J Med Res; 2004 Mar; 9(3):150-70. PubMed ID: 15096326
[TBL] [Abstract][Full Text] [Related]
27. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
[TBL] [Abstract][Full Text] [Related]
28. DVT and pulmonary embolism: Part II. Treatment and prevention.
Ramzi DW; Leeper KV
Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
[TBL] [Abstract][Full Text] [Related]
29. [Acute superficial thrombophlebitis--therapeutic strategies].
Noppeney T; Noppeney J; Winkler M; Kurth I
Zentralbl Chir; 2006 Feb; 131(1):51-6. PubMed ID: 16485211
[TBL] [Abstract][Full Text] [Related]
30. [Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis].
Alonso Martínez JL; Abínzano Guillén ML; Urbieta Echezarreta MA; Annichérico Sánchez FJ; Fernández Ladrón V; García Sanchotena JL
An Med Interna; 2008 Jan; 25(1):4-8. PubMed ID: 18377187
[TBL] [Abstract][Full Text] [Related]
31. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
32. Early discharge of patients with venous thromboembolism: implications regarding therapy.
Stein PD; Hull RD; Matta F; Yaekoub AY
Clin Appl Thromb Hemost; 2010 Apr; 16(2):141-5. PubMed ID: 19833629
[TBL] [Abstract][Full Text] [Related]
33. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity.
Savage KJ; Wells PS; Schulz V; Goudie D; Morrow B; Cruickshank M; Kovacs MJ
Thromb Haemost; 1999 Sep; 82(3):1008-10. PubMed ID: 10494754
[TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight heparin in the treatment of pulmonary embolism.
Ageno W; Turpie AG
Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
[TBL] [Abstract][Full Text] [Related]
36. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
Naz R; Naz S; Mehboob M; Khalid GH
J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and prophylaxis for deep venous thrombosis in neurosurgery.
Smith SF; Biggs MT; Sekhon LH
Surg Technol Int; 2005; 14():69-76. PubMed ID: 16525957
[TBL] [Abstract][Full Text] [Related]
38. Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins.
Siragusa S; Anastasio R; Porta C; Falaschi F; Pirrelli S; Palmieri P; Gamba G; Granzow K; Malato A; Minardi V; Tatoni P; Bressan MA; Mariani G
Arch Intern Med; 2004 Dec 13-27; 164(22):2477-82. PubMed ID: 15596639
[TBL] [Abstract][Full Text] [Related]
39. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
Epstein NE
Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
[TBL] [Abstract][Full Text] [Related]
40. Thromboembolism prophylaxis and incidence of thromboembolic complications after laparoscopic surgery.
Catheline JM; Capelluto E; Gaillard JL; Turner R; Champault G
Int J Surg Investig; 2000; 2(1):41-7. PubMed ID: 12774337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
